What the Study Found (In Plain English)
Published in Journal of child neurology (2008), this randomized controlled trial evaluating human clinical outcomes investigated: Previous studies suggested that melatonin improves sleep in insomniac patients with Angelman syndrome. Key clinical takeaway: Parents were satisfied with these results. Indications that melatonin dose in Angelman syndrome patients should be low, are discussed.
Dr. Lin (AI Evidence Lead): Statistical Endpoints & Numbers
Primary Endpoint & Quantitative Summary (Journal of child neurology, 2008-06-15; Randomized Controlled Trial; Rigor 88/100): Parents were satisfied with these results. Indications that melatonin dose in Angelman syndrome patients should be low, are discussed.
Study Limitations & Caveats Before You Act
Clinical trials evaluate specific inclusion/exclusion cohorts under protocol-controlled conditions (Randomized Controlled Trial). Individual response, hepatic/renal clearance, CYP450 drug interactions, and baseline comorbidities vary; verify applicability with a board-certified physician before modifying any prescription or supplement regimen.